CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors
Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment of hematologic malignancies, yet its efficacy in solid tumors and durability across broader application remain limited. A central challenge lies in how CAR signaling is initia…